7
1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7180 | Sultopride hydrochloride | LIN-1418 hydrochloride | Dopamine Receptor |
Sultopride hydrochloride (LIN-1418 hydrochloride) is a selective dopamine D2 and D3 receptor antagonist. | |||
T5678 | Lazabemide hydrochloride | N-(2-Aminoethyl)-5-chlor-2-pyridincarbox | MAO , Monoamine Oxidase |
Lazabemide hydrochloride (N-(2-Aminoethyl)-5-chlor-2-pyridincarbox) is a reversible and selective mao-b inhibitor(Ki:7.9nM). | |||
T5470 | LAZABEMIDE | Ro 19-6327 | MAO , Monoamine Oxidase |
Lazabemide (Ro 19-6327) is selective, reversible monoamine oxidase B (MAO-B) inhibitor (IC50 values are 0.03 and > 100 μM for MAO-B and MAO-A respectively). | |||
T126370 | Dopacetamide | ||
Dopacetamide is a useful organic compound for research related to life sciences. The catalog number is T126370 and the CAS number is 1129-53-9. | |||
T12483 | Piperidine-MO-1 | Others | |
Piperidine-MO-1 is a dopamine receptor modulator, with an ED50 of 68 μmol/kg on increase of DOPAC in the rat striatum. | |||
T26997 | CGP-28014 | ||
CGP-28014 is an inhibitor of catechol-O-methyltransferase. CGP-28014 increases the renal excretion of both dopamine and dihydroxyphenylacetic acid (DOPAC) but does not affect renal sodium handling indicating a different ... | |||
T37533 | DOPAL | ||
DOPAL is an aldehyde product of the oxidative deamination of dopamine by monoamine oxidase.[1] It can be further oxidized to 3,4-dihydroxyphenylacetic acid (DOPAC) by aldehyde dehydrogenase (ALDH) and, to a lesser extent... |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T4907 | 3,4-Dihydroxybenzeneacetic acid | DOPAC,3,4-Dihydroxyphenylacetic acid | Endogenous Metabolite |
3,4-Dihydroxybenzeneacetic acid (3,4-Dihydroxyphenylacetic acid) is the main metabolite of dopamine. |